120 related articles for article (PubMed ID: 7172943)
1. A method of clinical prognostic staging for patients with rectal cancer.
Zorzitto M; Germanson T; Cummings B; Boyd NF
Dis Colon Rectum; 1982; 25(8):759-65. PubMed ID: 7172943
[TBL] [Abstract][Full Text] [Related]
2. Surgeon-related factors and outcome in rectal cancer.
Porter GA; Soskolne CL; Yakimets WW; Newman SC
Ann Surg; 1998 Feb; 227(2):157-67. PubMed ID: 9488510
[TBL] [Abstract][Full Text] [Related]
3. Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer.
Gosens MJ; van Krieken JH; Marijnen CA; Meershoek-Klein Kranenbarg E; Putter H; Rutten HJ; Bujko K; van de Velde CJ; Nagtegaal ID;
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):997-1003. PubMed ID: 17544876
[TBL] [Abstract][Full Text] [Related]
4. A new prognostic classification of rectal cancer.
Jass JR; Love SB; Northover JM
Lancet; 1987 Jun; 1(8545):1303-6. PubMed ID: 2884421
[TBL] [Abstract][Full Text] [Related]
5. New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis.
Greene FL; Stewart AK; Norton HJ
J Clin Oncol; 2004 May; 22(10):1778-84. PubMed ID: 14769855
[TBL] [Abstract][Full Text] [Related]
6. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
[TBL] [Abstract][Full Text] [Related]
7. [TNM staging, molecular staging and prognostic factors of rectal cancer].
Lee SH
Korean J Gastroenterol; 2006 Apr; 47(4):291-4. PubMed ID: 16632980
[TBL] [Abstract][Full Text] [Related]
8. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
[TBL] [Abstract][Full Text] [Related]
9. [Liver metastases from colon and rectal cancer in terms of differences in their clinical parameters].
Liška V; Emingr M; Skála M; Pálek R; Troup O; Novák P; Vyčítal O; Skalický T; Třeška V
Rozhl Chir; 2016 Feb; 95(2):69-77. PubMed ID: 27008168
[TBL] [Abstract][Full Text] [Related]
10. Predicting prognosis of rectal cancer patients with total mesorectal excision using molecular markers.
Peng JJ; Cai SJ; Lu HF; Cai GX; Lian P; Guan ZQ; Wang MH; Xu Y
World J Gastroenterol; 2007 Jun; 13(21):3009-15. PubMed ID: 17589956
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of lymph node ratio in a national cohort of rectal cancer patients.
Lykke J; Jess P; Roikjaer O;
Eur J Surg Oncol; 2016 Apr; 42(4):504-12. PubMed ID: 26856955
[TBL] [Abstract][Full Text] [Related]
12. A reappraisal of staging and therapy for patients with cancer of the rectum. I. Development of two new systems of staging.
Feinstein AR; Schimpff CR; Hull EW
Arch Intern Med; 1975 Nov; 135(11):1441-53. PubMed ID: 1190929
[TBL] [Abstract][Full Text] [Related]
13. Relative prognostic value of the Dukes and the Jass systems in rectal cancer. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01).
Fisher ER; Robinsky B; Sass R; Fisher B
Dis Colon Rectum; 1989 Nov; 32(11):944-9. PubMed ID: 2478350
[TBL] [Abstract][Full Text] [Related]
14. Prognostic staging of extraperitoneal rectal cancer.
Henrichsen S; Christiansen J
Dis Colon Rectum; 1989 Mar; 32(3):214-8. PubMed ID: 2920628
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of rectum carcinoma--experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma.
Hermanek P; Wiebelt H; Staimmer D; Riedl S
Tumori; 1995; 81(3 Suppl):60-4. PubMed ID: 7571056
[TBL] [Abstract][Full Text] [Related]
16. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.
Moertel CG; O'Fallon JR; Go VL; O'Connell MJ; Thynne GS
Cancer; 1986 Aug; 58(3):603-10. PubMed ID: 3731019
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of lymph node ratio staging system in stage III( rectal cancer following 30 Gy/10 f preoperative radiotherapy].
Wang L; Li Z; Li M; Peng Y; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Oct; 17(10):990-6. PubMed ID: 25341906
[TBL] [Abstract][Full Text] [Related]
18. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
19. [Current MRI staging of rectal cancer].
Wietek BM; Kratt T
Rofo; 2012 Nov; 184(11):992-1001. PubMed ID: 22893486
[TBL] [Abstract][Full Text] [Related]
20. Mandard tumour regression grade, perineural invasion, circumferential resection margin and post-chemoradiation nodal status strongly predict outcome in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Dhadda AS; Bessell EM; Scholefield J; Dickinson P; Zaitoun AM
Clin Oncol (R Coll Radiol); 2014 Apr; 26(4):197-202. PubMed ID: 24485884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
